Kim Garrett, LCSW accepts new patients on Medical News Today.
Kim Garrett, LCSW
Be the first to review this provider!
Cleburne, TX
Accepting new patients
Clinical Overview
Kim Garrett, LCSW works in Cleburne, TX as
Office Locations
-
Everyday People Counseling & Therapy PLLC212 N Anglin St, Cleburne, TX 76031
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Kim Garrett?
Step 1 of 3
Your review of Kim Garrett, LCSW
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Counseling
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Kim Garrett's office is located at 212 N Anglin St Cleburne, TX 76031. Get a map and directions to Kim Garrett's office here.
Kim Garrett does not have any reviews yet.
Claim Your Profile
Are you Kim Garrett, LCSW?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
Researchers have developed a new AI tool that could help predict the risk of distant breast cancer recurrence. In particular, it could help predict the risk of breast cancer returning 5 years or more after treatment.
The FDA has cleared two new blood tests for Alzheimer’s disease, Roche’s Elecsys pTau217 and C2N Diagnostics’ PrecivityAD2, which could help support earlier Alzheimer’s disease detection.
About one in five people who experienced a mini-stroke later received a dementia diagnosis, a new study has found.
